Horizon (HZNP) Gets Positive CHMP Opinion for Uplizna in NMOSD Posted byZacks Equity Research November 15, 2021 Leave a comment on Horizon (HZNP) Gets Positive CHMP Opinion for Uplizna in NMOSD The CHMP gives a positive opinion on, and recommends approval to Horizon’s (HZNP) Uplizna for treating adult patients with neuromyelitis optica spectrum disorder.